A Phase I Trial of Vorinostat in Combination With Bevacizumab & Irinotecan in Recurrent Glioblastoma

Mise à jour : Il y a 4 ans
Référence : NCT00762255

Femme et Homme

Extrait

The purpose of the this study is to see if an investigations cancer treatment called vorinostat can be combined with the irinotecan/bevacizumab regimen safely.


Critère d'inclusion

  • Glioblastoma

Liens